• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES EZ GLIDE AORTIC CANNULAE; AORTIC PERFUSION CANNULAE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES EZ GLIDE AORTIC CANNULAE; AORTIC PERFUSION CANNULAE Back to Search Results
Model Number EZC21A
Device Problems Device Contamination with Chemical or Other Material (2944); Insufficient Information (3190)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/21/2019
Event Type  malfunction  
Manufacturer Narrative
The device was returned for evaluation.The evaluation is anticipated but has not yet begun.A supplemental report will be submitted upon completion.
 
Event Description
It was reported that a black particulate was found inside cannula when opening the package before use.The size of the particulate was 2-3 mm, and it was likely to be the ew logo which was printed on the outside of this cannula.There were no patient complications reported.
 
Manufacturer Narrative
Japan warehouse complaint of "black particulate" was confirmed.As received, an unknown loose black particulate was found already isolated from the cannula.As received, the device appeared to have incomplete printing on the wired reinforced section of the cannula.Upon examination, the non-wired section of the cannula appeared to have unknown contaminates.Device was sent to chemistry lab for ft-ir analysis.No other visual damage, contamination, or other abnormalities were found to the device.Engineering task has been opened and assigned for further investigation.A supplemental report will be submitted.
 
Manufacturer Narrative
Device was sent to chemistry lab for ft-ir analysis.The particulate was removed from the sample slide and scanned by diamond atr.Particulate was broken into two pieces, measuring at 1674 m by 640 m for an area measurement of 1,071,360 m² and 1446 m by 678 m for an area measurement of 980,388 m².The ft-ir spectrum showed similar absorption characteristics to acrylic polymer like material.The complaint is confirmed.Per the product evaluation and chemistry evaluation, the complaint of "black particulate" was confirmed.Per the engineering evaluation, a manufacturing defect was confirmed.A supplier, design, ifu, and labeling defect were not confirmed.The trend is in control and the fmea line item is appropriate.Pra was initiated and the root cause will be investigated in capa.The device history record (dhr) was reviewed and showed that this device met all manufacturing and sterilization specifications for product release prior to distribution.No issues were identified that would have impacted this event.Edwards will continue to review and monitor all events.Trends are monitored on a monthly basis and if action is required, appropriate investigation will be performed.
 
Manufacturer Narrative
Reference capa-20-00141.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EZ GLIDE AORTIC CANNULAE
Type of Device
AORTIC PERFUSION CANNULAE
Manufacturer (Section D)
EDWARDS LIFESCIENCES
one edwards way
irvine CA 92614
MDR Report Key8793708
MDR Text Key151328429
Report Number3008500478-2019-00151
Device Sequence Number1
Product Code DWF
Combination Product (y/n)N
PMA/PMN Number
K123370
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Type of Report Initial,Followup,Followup,Followup
Report Date 06/21/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberEZC21A
Device Catalogue NumberEZC21A
Device Lot Number61438670
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/12/2019
Initial Date Manufacturer Received 06/21/2019
Initial Date FDA Received07/16/2019
Supplement Dates Manufacturer Received07/31/2019
09/16/2019
07/23/2020
Supplement Dates FDA Received08/22/2019
09/24/2019
01/10/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-